Home > PJ (current issue) > News / Daily News | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7330 p873-878
18/25 December 2004

This section
Reprint   Photocopy

PDF 350K, Acrobat Reader

News summary

DIARY   Branch meetings   Future Events   Conferences

873 Consultation seeks views on skill mix in pharmacy A consultation document on making better use of a range of skills in pharmacy was launched this week by health minister Rosie Winterton ...more

873 NHS logos for community pharmacies in England launched at Essex pharmacy NHS branding for community pharmacies in England was officially launched this week at Barry Shooter pharmacy in Ilford, Essex ...more

873 PPRS price cut delayed to ensure supplies Community pharmacies in England, Scotland and Wales have been granted one month’s grace before an agreed 7 per cent cut in medicine prices is implemented for NHS reimbursement purposes ...more

874 Latest Shipman report may affect Society’s roles Criticisms of the General Medical Council made in the latest Shipman Inquiry report could have implications for the Royal Pharmaceutical Society ...more

874 CD registers are to be centralised at Prescription Pricing Authority Central records of all community pharmacy Controlled Drug registers are to be kept by the Prescription Pricing Authority once electronic CD registers are in common use ...more

875 Scotland moves away from volume-based contract Community pharmacists in Scotland look likely to have a new contract that moves away from payment by prescription volume for the first time. Instead, subject to the agreement of contractors, the contract will be based on a capitation payment for two of the four core services, a fixed practice payment for one and a volume-based payment for the remaining service ...more

875 Transitional funding agreed in Scotland Transitional funding arrangements, to cover the 15 months until the new community pharmacy contract in Scotland is implemented in April 2006, were announced this week ...more

875 First cohort of supplementary prescribers qualify in Wales An awards ceremony was held at Cardiff University earlier this month for the 47 pharmacists and nurses who have just qualified as supplementary prescribers from the University’s Welsh School of Pharmacy and School of Nursing and Midwifery Studies ...more

876 Barcodes may be best way in short term to identify patients, says NPSA Technologies such as barcodes, radio frequency identification and biometrics could help improve patient safety in the NHS by ensuring that patients are correctly identified, according to studies commissioned by the National Patient Safety Agency ...more

876 NPA appoints new managers to help its members Two new managers to help community pharmacists develop their businesses have been appointed by the National Pharmaceutical Association ...more

876 Lloyds offers £10k for long service Preregistration trainees working for Lloydspharmacy are being offered an incentive to stay with the company ...more

876 PGD website A website, run by the London and South East Medicines Information Service and providing resources for patient group directions, was launched this week ...more

877 Parasitic worms benefit Crohn’s disease patients Parasitic worms may be a safe and effective treatment for Crohn’s disease, new research suggests ...more

877 BP trial is halted early A trial comparing blood-pressure-lowering treatments has been stopped early after one of the treatment arms was found to offer significant advantages to patients ...more

877 Poor technique a problem with new inhalers Newer dry powder inhalers are ineptly used as often as older pressurised metered dose inhalers, a new study suggests ...more

877 Antiemetic also provides pain relief in migraine Metoclopramide, an antiemetic, effectively reduces headache pain associated with acute migraine and should be considered a primary treatment option in accident and emergency departments, say researchers ...more

877 Rivastigmine reduces dementia in Parkinson’s Rivastigmine (Exelon) treatment is associated with moderate reductions in dementia associated with Parkinson’s disease, a new study has shown ...more

878 Treatment duration of action is important in ED Duration of action of erectile dysfunction treatment appears to be the most important factor when patients are able to choose which product to use, data from three patient preference studies suggest ...more

878 Workshop examines new process analytical technology guidance for manufacturers Representatives from UK and US regulatory agencies met pharmaceutical industry professionals earlier this week to discuss new US Food and Drug Administration guidance on process analytical technology (PAT) ...more

878 Pharmacists should distance themselves from industry Nofreelunch, an international organisation that wants to break the hospitality and patronage-based relationship between health professionals and the pharmaceutical industry, is asking pharmacists to distance themselves from the industry ...more

878 Lilly’s trial registry launched Lilly has launched its online registry of clinical trials of its products ...more

878 Novartis corrects misleading Clozaril statement Novartis Pharmaceuticals has issued a corrective statement at the request of the Medicines and Healthcare products Regulatory Agency following the voluntary withdrawal earlier this year of two promotional booklets for Clozaril (clozapine) ...more

Back to Top


©The Pharmaceutical Journal